Product

Recombinant Novel Coronavirus Protein Vaccine

1 clinical trial

1 indication

Indication
COVID-19
Clinical trial
Anhui Zhifei Longcom Biologic Pharmacy co. Ltd.
Status: Recruiting, Estimated PCD: 2023-07-30